Scientists at the IRCM and the University of Montreal discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found ...
Oct 14, 2014
0
0
Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found that a protein known as Sonic ...
Oct 2, 2014
0
0
Two Johns Hopkins neuroscientists have discovered the "molecular brakes" that time the generation of important cells in the inner ear cochleas of mice. These "hair cells" translate sound waves into electrical signals that ...
Sep 16, 2014
0
0
An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help ...
Aug 24, 2014
0
0
A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine.
Apr 20, 2014
0
0
Cell migration is highly coordinated and occurs in processes such as embryonic development, wound healing, the formation of new blood vessels, and tumour cell invasion. For the successful control of cell movement, this process ...
Mar 21, 2014
0
0
A research team from Imperial College London has shown that blocking the function of an enzyme known as Hhat slows the growth and spread of pancreatic cancer, by preventing a protein called Hedgehog from stimulating nearby ...
Mar 12, 2014
0
0
(Medical Xpress)—Decades of research and millions of dollars go into developing new cancer drugs from scratch. But what if the next cure is a pill that's already tucked away in a bottle at the local pharmacy?
Feb 4, 2014
0
0
In 2013 the European Medicines Agency approved the use of a new anti-cancer drug, Erivedge, developed by Genentech in collaboration with the Cambridge (Mass) based biotech company Curis Inc, for the treatment of Basal Cell ...
Nov 20, 2013
0
0
Researchers at Johns Hopkins and the National Institutes of Health have identified a compound that dramatically bolsters learning and memory when given to mice with a Down syndrome-like condition on the day of birth. As they ...
Sep 4, 2013
0
0
